Oruka Therapeutics (ORKA) Operating Expenses (2010 - 2024)
Oruka Therapeutics' quarterly Operating Expenses came in at $3.1 million in Q2 2024, up 58.24% year-on-year from $2.0 million in Q3 2023, and up 25.79% quarter-over-quarter from $2.5 million in Q1 2024.
Oruka Therapeutics has reported Operating Expenses for 15 years, with the latest figure at $3.1 million in Q2 2024.
- For the quarter ending Q2 2024, Operating Expenses rose 58.24% year-over-year to $3.1 million; the trailing twelve-month figure through Mar 2025 stood at $3.1 million (down 60.89% YoY), and the FY2023 full-year result was $7.3 million, down 31.14% from the prior year.
- Operating Expenses for Q2 2024 stood at $3.1 million, up from $2.5 million in the prior quarter.
- The five-year high for Operating Expenses was $5.7 million in Q4 2021, with the low at $1.3 million in Q2 2020.
- Average Operating Expenses over 5 years is $2.9 million, with a median of $2.5 million recorded in 2022.
- Year-over-year, Operating Expenses surged 301.1% in 2020 and sank 72.75% in 2022.
- Tracing ORKA's Operating Expenses over 5 years: stood at $5.1 million in 2020, then grew by 10.81% to $5.7 million in 2021, then slumped by 72.75% to $1.5 million in 2022, then increased by 2.71% to $1.6 million in 2023, then surged by 96.35% to $3.1 million in 2024.
- The last three Operating Expenses figures came in at $3.1 million (Q2 2024), $2.5 million (Q1 2024), and $1.6 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.33 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -138.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.85 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.96 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 898.54 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 3.12 Mn |
| Mar 31, 2024 | 2.48 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 1.94 Mn |
| Jun 30, 2023 | 1.97 Mn |
| Mar 31, 2023 | 1.80 Mn |
| Dec 31, 2022 | 1.55 Mn |
| Sep 30, 2022 | 2.55 Mn |
| Jun 30, 2022 | 3.22 Mn |
| Mar 31, 2022 | 3.28 Mn |
| Dec 31, 2021 | 5.68 Mn |
| Sep 30, 2021 | 4.72 Mn |
| Jun 30, 2021 | 4.84 Mn |
| Mar 31, 2021 | 4.10 Mn |
| Dec 31, 2020 | 5.13 Mn |
| Sep 30, 2020 | 1.99 Mn |
| Jun 30, 2020 | 1.31 Mn |
| Mar 31, 2020 | 1.34 Mn |
| Dec 31, 2019 | 1.28 Mn |
| Sep 30, 2019 | 1.25 Mn |
| Jun 30, 2019 | 1.51 Mn |
| Mar 31, 2019 | 1.78 Mn |
| Dec 31, 2018 | 1.53 Mn |
| Sep 30, 2018 | 1.66 Mn |
| Jun 30, 2018 | 2.16 Mn |
| Mar 31, 2018 | 2.77 Mn |
| Dec 31, 2017 | 4.30 Mn |
| Sep 30, 2017 | 4.48 Mn |
| Jun 30, 2017 | 5.56 Mn |
| Mar 31, 2017 | 4.38 Mn |
| Dec 31, 2016 | 4.29 Mn |
| Sep 30, 2016 | 4.71 Mn |
| Jun 30, 2016 | 3.94 Mn |
| Mar 31, 2016 | 3.67 Mn |
| Dec 31, 2015 | 3.18 Mn |
| Sep 30, 2015 | 2.82 Mn |
| Jun 30, 2015 | 2.72 Mn |
| Mar 31, 2015 | 2.74 Mn |
| Dec 31, 2014 | 2.61 Mn |
| Sep 30, 2014 | 2.29 Mn |
| Jun 30, 2014 | 2.41 Mn |
| Mar 31, 2014 | 2.39 Mn |
| Dec 31, 2013 | 2.95 Mn |
| Sep 30, 2013 | 1.73 Mn |
| Jun 30, 2013 | 1.20 Mn |
| Mar 31, 2013 | 1.07 Mn |
| Dec 31, 2012 | 839,000.00 |
| Sep 30, 2012 | 928,000.00 |
| Jun 30, 2012 | 1.15 Mn |
| Mar 31, 2012 | 1.41 Mn |
| Dec 31, 2011 | 1.63 Mn |
| Sep 30, 2011 | 1.82 Mn |
| Jun 30, 2011 | 1.70 Mn |
| Mar 31, 2011 | 2.20 Mn |
| Dec 31, 2010 | 2.35 Mn |
| Sep 30, 2010 | 2.11 Mn |
| Jun 30, 2010 | 2.27 Mn |